Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -199,352 | -122,560 | -50,777 | -360,395 | -339,006 |
| Depreciation Amortization | 13,981 | 8,711 | 3,690 | 11,926 | 8,585 |
| Accounts receivable | 31,807 | 30,534 | 29,830 | -35,689 | 3,864 |
| Accounts payable and accrued liabilities | -885 | -1,195 | 750 | 8,840 | -826 |
| Other Working Capital | 18,257 | 13,202 | 12,780 | -29,401 | -20,802 |
| Other Operating Activity | 116 | -10,403 | -22,528 | 239,078 | 219,179 |
| Operating Cash Flow | $-136,076 | $-81,711 | $-26,255 | $-165,641 | $-129,006 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -389,455 | -444,602 | -338,930 | -514,853 | -539,814 |
| PPE Investments | -9,851 | -3,374 | -2,110 | -8,961 | -5,435 |
| Net Acquisitions | N/A | N/A | N/A | -25,000 | -25,000 |
| Other Investing Activity | -288 | -288 | -288 | 0 | 0 |
| Investing Cash Flow | $-399,594 | $-448,264 | $-341,328 | $-548,814 | $-570,249 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 610,012 | 606,181 | 598,984 | 752,457 | 744,772 |
| Common Stock Repurchased | -303 | -123 | 0 | -15,992 | -15,965 |
| Financing Cash Flow | $609,709 | $606,058 | $598,984 | $736,465 | $728,807 |
| Beginning Cash Position | 75,179 | 75,179 | 75,179 | 53,169 | 53,169 |
| End Cash Position | 149,218 | 151,262 | 306,580 | 75,179 | 82,721 |
| Net Cash Flow | $74,039 | $76,083 | $231,401 | $22,010 | $29,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,076 | -81,711 | -26,255 | -165,641 | -129,006 |
| Capital Expenditure | -9,851 | -3,374 | -2,110 | -8,961 | -5,435 |
| Free Cash Flow | -145,927 | -85,085 | -28,365 | -174,602 | -134,441 |